New York has set a six-year statute of limitation to bring charges under the Martin Act. The deadline issue has been a bone of contention in a court case between the state attorney general and Credit Suisse.

Nonprime securitization was down for the second straight quarter and the S&D market was sluggish. But prime-jumbo and ECM production rose sharply in the third quarter. (Includes three data charts.)

In an effort to receive favorable capital treatment for credit-risk transfer on non-agency mortgages, JPMorgan Chase is preparing a unique deal.

Non-agency MBS issuers are focusing on deals backed by a single product, because they are a better gauge of prepayment speeds.

Presidential candidate Elizabeth Warren has flagged concerns about the issuer-pays model used by credit rating agencies for securitized products. She said the SEC hasn’t done enough to address the conflicts of interest tied to the model.

Some investors prefer buying non-agency mortgages via whole loan transactions rather than stocked in MBS. Whole loans offer better yields and more loan information.

The San Francisco-based lender is prepping a $200 million ABS stocked with home-equity lines of credit originated using blockchain technology.

Low interest rates, along with better alignment of incentives between issuers and investors, are helping boost demand for securitized assets.

Market participants are finding it difficult to move away from LIBOR in the absence of an alternative rate and because of document-related issues.

REITs, which have become key investors in MBS and MSRs, may get another crack at FHLB membership if the Trump administration gets its way. The golden chalice: discount advances available via the borrowing window.